Literature DB >> 9837740

Self-interaction of pneumolysin, the pore-forming protein toxin of Streptococcus pneumoniae.

R J Gilbert1, J Rossjohn, M W Parker, R K Tweten, P J Morgan, T J Mitchell, N Errington, A J Rowe, P W Andrew, O Byron.   

Abstract

The pathogenically important cholesterol-binding pore-forming bacterial "thiol-activated" toxins (TATs) are commonly believed to be monomeric in solution and to undergo a transition on membrane binding mediated by cholesterol to an oligomeric pore. We present evidence, gained through the application of a number of biochemical and biophysical techniques with associated modelling, that the TAT from Streptococcus pneumoniae, pneumolysin, is in fact able to self-associate in solution to form the same oligomeric structures. The weak interaction leading to solution oligomerization is manifested at low concentrations in a dimeric toxin form. The inhibition of toxin self-interaction by derivatization of the single cysteine residue in pneumolysin with the thiol-active agent dithio (bis)nitrobenzoic acid indicates that self-interaction is mediated by the fourth domain of the protein, which has a fold similar to other proteins known to self-associate. This interaction is thought to have implications for the understanding of mechanisms of pore formation and complement activation by pneumolysin. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837740     DOI: 10.1006/jmbi.1998.2258

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  25 in total

1.  The solution structure and oligomerization behavior of two bacterial toxins: pneumolysin and perfringolysin O.

Authors:  Alexandra S Solovyova; Marcelo Nöllmann; Timothy J Mitchell; Olwyn Byron
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

2.  CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

Authors:  Aras Kadioglu; William Coward; M Joseph Colston; Colin R A Hewitt; Peter W Andrew
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 3.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

4.  Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.

Authors:  Lea-Ann S Kirkham; Alison R Kerr; Gill R Douce; Gavin K Paterson; Deborah A Dilts; Dai-Fang Liu; Tim J Mitchell
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae.

Authors:  G Zysk; B K Schneider-Wald; J H Hwang; L Bejo; K S Kim; T J Mitchell; R Hakenbeck; H P Heinz
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  Toll-like receptor (TLR) 2 mediates inflammatory responses to oligomerized RrgA pneumococcal pilus type 1 protein.

Authors:  Alan Basset; Fan Zhang; Cyril Benes; Sabina Sayeed; Muriel Herd; Claudette Thompson; Douglas T Golenbock; Andrew Camilli; Richard Malley
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

Review 7.  Perfringolysin O structure and mechanism of pore formation as a paradigm for cholesterol-dependent cytolysins.

Authors:  Benjamin B Johnson; Alejandro P Heuck
Journal:  Subcell Biochem       Date:  2014

8.  Effects of the eukaryotic pore-forming cytolysin Equinatoxin II on lipid membranes and the role of sphingomyelin.

Authors:  Boyan B Bonev; Yuen-Han Lam; Gregor Anderluh; Anthony Watts; Raymond S Norton; Frances Separovic
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

9.  The role of cholesterol in the activity of pneumolysin, a bacterial protein toxin.

Authors:  Marcelo Nöllmann; Robert Gilbert; Timothy Mitchell; Michele Sferrazza; Olwyn Byron
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033

10.  Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells.

Authors:  Daniel R Neill; William R Coward; Jenna F Gritzfeld; Luke Richards; Francesc J Garcia-Garcia; Javier Dotor; Stephen B Gordon; Aras Kadioglu
Journal:  Am J Respir Crit Care Med       Date:  2014-05-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.